Akebia Therapeutics Inc
MNKD or AKBA: Which Is Expected to Report Faster Revenue Growth?
On December 13, 2018, Akebia Therapeutics issued a press release announcing the completion of its merger with Keryx Biopharmaceuticals.
What Analysts Are Recommending for MannKind and Akebia in March
On March 12, MannKind Corporation (MNKD) closed at $2.09, 8.29% higher than its previous closing price.
Is Seth Klarman Making Money on His New eBay Bet?
During the fourth quarter, Seth Klarman added 21 million shares of eBay (EBAY) worth $589 million to his portfolio.
Akebia Therapeutics and Keryx Biopharmaceuticals’ Proposed Merger
Today, Akebia Therapeutics (AKBA) and Keryx Biopharmaceuticals (KERX) announced an all-stock merger.
Analysts’ Ratings for Athenex and Its Peers in March
Of the six analysts covering Athenex in March 2018, five analysts gave the stock a “buy” rating, while one analyst gave it a “hold” rating.
How Analysts View Agios Pharmaceuticals and Peers in March 2018
Of the nine analysts covering Agios Pharmaceuticals (AGIO) in March 2018, one gave it a “strong buy” rating, and six gave it a “buy” rating.